Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 91-95

  Bouffet, E ^a,c   Mottolese, C ^b   Jouvet, A ^b   Philip, I ^a   Frappaz, D ^a   Carrie, C ^a   Brunat Mentigny, M ^a  

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

bone marrow transplantation; chemotherapy; child; malignant glioma

Indexed keywords

ETOPOSIDE; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLIOMA; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SURVIVAL RATE; THIOTEPA;

EID: 0031020992     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00369-3     Document Type: Article

References (28)

1. 1. Pollack IF. Brain tumors in children. N Engl J Med 1994, 331, 1500-1507.
2. 2. Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol 1995, 13, 112-123.
3. 3. Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy: clinical characteristics and treatment related toxicities. Cancer 1996, 77, 555-562.
4. 4. Syndikus I, Tait D, Ashley S, Jannoun L. Long-term follow-up of young children with brain tumors after irradiation. Int J Radiat Oncol Biol Phys 1994, 30, 781-787.
5. 5. Sposto R, Ertel IJ, Jenkin V, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children. Result of a randomized trial. A report from the Children's Cancer Study Group. J Neuro-oncol 1989, 7, 165-177.
6. 6. Heideman RL, Douglass EC, Krance RA, et al. High dose chemotherapy and autologous bone marrow rescue followed by interstitial and external beam radiation therapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 1993, 11, 1458-1465.
7. 7. Kedar A, Maria BL, Graham Pole J, et al. High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med Ped Oncol 1994, 23, 428-436.
8. 8. Finlay JL, August C, Packer R, et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neuro-oncol 1990, 9, 239-248.
9. 9. Kalifa C, Hartmann O, Demeocq F, et al. High-dose busulfan and thiotepa and autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 1992, 9, 227-233.
10. 10. Mahoney DH Jr, Strother D, Camitta B, et al. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot Pediatric Oncology Group study. J Clin Oncol 1996, 14, 382-388.
11. 11. Stewart DJ. The role of chemotherapy in the treatment of gliomas in adults. Cancer Treat Rev 1989, 16, 129-160.
12. 12. Biron P, Bouffet E. High-dose chemotherapy and hematopoietic cell support in brain tumors. In Dicke KA, Keating A, eds. Autologous Marrow and Blood Transplantation. Houston, Proceedings VII International Symposium, 1995, 451-452.
13. 13. Kessinger A. High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results. Neurosurgery 1984, 15, 747-750.
14. 14. Wolff SN, Phillips GL, Herzig GP. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Cancer Treat Rep 1987, 71, 183-185.
15. 15. Johnson DB, Thompson JM, Corwin JA, et al. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. J Clin Oncol 1987, 5, 783-789.
16. 16. Lesser GJ, Grossman S. The chemotherapy of high-grade astrocytomas. Semin Oncol 1994, 21, 220-235.
17. 17. Rodriguez L, Levin V. Does chemotherapy benefit the patients with a central nervous system glioma? Oncology 1987, 9, 29-36.
18. 18. Tartaglia RL, Cole DE, Heideman R, et al. Chemosensitivity of central nervous system tumors to thiotepa and tepa. Proc Am Assoc Cancer Res 1989, 30, 461-(abstract).
19. 19. Heideman RL, Cole DE, Balis F, et al. Phase I and pharmacokinetics evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose dependent plasma clearance of thiotepa. Cancer Res 1989, 49, 736-741.
20. 20. Razzouk BI, Heideman RL, Friedman HS, et al. A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer 1995, 75, 2762-2767.
21. 21. Ahmed T, Feldman E, Helson L, et al. Phase 1-2 trial of high dose thiotepa with autologous bone marrow transplantation and localized radiotherapy for patients with astrocytoma grade III-IV. Proc Am Assoc Cancer Res 1990, 31, 172-(abstract).
22. 22. Tirelli U, D'Incalci M, Canetta R, et al. Etoposide in malignant brain tumors: a phase II study. J Clin Oncol 1984, 2, 432-437.
23. 23. Giannone L, Wolff SN. Phase II treatment of central nervous system gliomas with high dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 1987, 71, 759-761.
24. 24. Kramer ED, Finlay JL, Packer RJ, Goldman S, Shen V, Harris R, Ginsberg J. Neurotoxicity (NTX) associated with high-dose chemotherapy and autologous bone marrow rescue (HDCx + ABMR) for primary malignant brain tumors (MBT). Third International Conference on Long-term Complications of the Treatment of Children and Adolescents for Cancer, June 10-11, 1994, Niagara Falls, New York, Roswell Park Cancer Institute, Buffalo, New York, A38, 1994 (abstract).
25. 25. Leff RS, Thompson JM, Daly MB, et al. Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 1988, 62, 32-35.
26. 26. Wolff SN, Herzig RH, Fay JW, et al. High-dose N,N′,N″-riethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol 1990, 17 (Suppl. 3), 2-6.
27. 27. Wandt H, Birkmann J, Seifert M, et al. Localized cerebral edema after high-dose chemotherapy and ABMT for germ cell tumor. Bone Marrow Transplant 1993, 11, 419-420.
28. 28. Packer RJ. Re-evaluation of outcome in children with high grade glioma treated on a Children's Cancer Study Group CCG-943: a randomized study of radiation alone versus radiation plus adjuvant CCNU, prednisone and vincristine chemotherapy. 7th International Symposium of Pediatric Neurooncology, May 1996, Washington, District of Columbia (abstract).